Importantly, P2X4 is upregulated in many models involving microglial activation, such as neuropathic and inflammatory pain [24], migraine [18], ischemia [10], epilepticus [9], Alzheimer's disease [25], and amyotrophic lateral sclerosis [26], which is consistent with our research results. Here, P2RX4 is linked to migraine disorder.